Cytokinetics, Incorporated · NASDAQ:CYTK

Blum Robert I sold 7,500 Cytokinetics, Incorporated shares (Form 4)

Traded May 14, 2026 · Filed May 14, 2026

On May 14, 2026, Blum Robert I (Director, President & CEO) sold 7,500 Cytokinetics, Incorporated shares at US$77.92 for US$584K under a trading plan, leaving 400,330 shares. Filed May 14, 2026 (Form 4).

Sold
7,500 shares
Price
US$77.92
Value
US$584K
Holding after
400,330 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, President & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 14, 2026Common StockSale7,500US$77.92400,330Direct

Source

View original at SEC

Related